Trigeminal Neuralgia Therapeutic Pipeline Review Research H2 2014 Report Available at ReportsnReports.com

Share Article

ReportsnReports.com adds “Trigeminal Neuralgia - Pipeline Review, H2 2014” to its store. The report provides an overview of the Pancreatitis’s therapeutic pipeline.

Trigeminal Neuralgia Therapeutic Pipeline Review

Trigeminal Neuralgia Therapeutic Pipeline Review

The report "Trigeminal Neuralgia – Pipeline Review, H2 2014" provides comprehensive information on the therapeutic development for Trigeminal Neuralgia. Trigeminal neuralgia is a chronic pain condition that affects the trigeminal nerve, which carries sensation from face to brain. It is estimated that 1 in 15,000 or 20,000 people suffer from Trigeminal neuralgia, although the actual figure may be significantly higher due to frequent misdiagnosis. Trigeminal neuralgia can be caused by a blood vessel pressing on the trigeminal nerve as it exits the brain stem. Trigeminal neuralgia occurs most often in people over age 50, although it can occur at any age, including infancy. Complete Report is Available @ http://www.reportsnreports.com/reports/322758-trigeminal-neuralgia-pipeline-review-h2-2014.html .

It also reviews key players involved in the therapeutic development for Trigeminal Neuralgia and special features on late-stage and discontinued projects. Companies discussed in this Trigeminal Neuralgia Pipeline Review H2 2014 report include Allergan, Inc., Convergence Pharmaceuticals Ltd., Merz Pharma GmbH & Co. KgaA, Trigemina, Inc.

The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Order a Purchase copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=322758 . (This is a premium report priced at US$2000 for a single user License.)

Table of Contents

List of Tables
Number of Products under Development for Trigeminal Neuralgia, H2 2014 7
Number of Products under Development for Trigeminal Neuralgia - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Clinical Stage Development, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Comparative Analysis by Unknown Stage Development, H2 2014 12
Products under Development by Companies, H2 2014 13
Trigeminal Neuralgia - Pipeline by Allergan, Inc., H2 2014 14
Trigeminal Neuralgia - Pipeline by Convergence Pharmaceuticals Ltd., H2 2014 15
Trigeminal Neuralgia - Pipeline by Merz Pharma GmbH & Co. KgaA, H2 2014 16
Trigeminal Neuralgia - Pipeline by Trigemina, Inc., H2 2014 17
Assessment by Monotherapy Products, H2 2014 18
Assessment by Combination Products, H2 2014 19
Number of Products by Stage and Target, H2 2014 21
Number of Products by Stage and Mechanism of Action, H2 2014 23
Number of Products by Stage and Route of Administration, H2 2014 25
Number of Products by Stage and Molecule Type, H2 2014 27
Trigeminal Neuralgia Therapeutics - Recent Pipeline Updates, H2 2014 36

List of Figures
Number of Products under Development for Trigeminal Neuralgia, H2 2014 7
Number of Products under Development for Trigeminal Neuralgia - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Assessment by Monotherapy Products, H2 2014 18
Number of Products by Top 10 Targets, H2 2014 20
Number of Products by Stage and Top 10 Targets, H2 2014 21
Number of Products by Top 10 Mechanism of Actions, H2 2014 22
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 23
Number of Products by Top 10 Routes of Administration, H2 2014 24
Number of Products by Stage and Top 10 Routes of Administration, H2 2014 25
Number of Products by Top 10 Molecule Types, H2 2014 26
Number of Products by Stage and Top 10 Molecule Types, H2 2014 27

Explore more reports on Therapeutics industry at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics .

About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Ritesh Tiwari
@LifeSciReports
Follow >
Sandler Research
since: 04/2014
Like >
Follow us on
Visit website